San Antonio Claude D. Pepper Older Americans Independence Center
圣安东尼奥克劳德·D·佩珀美国老年人独立中心
基本信息
- 批准号:10670118
- 负责人:
- 金额:$ 124.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-15 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:4 year oldAccelerationAgingAlzheimer&aposs disease pathologyAmericanAwarenessBehavior TherapyBiology of AgingBiometryCallithrixCapsicumCell AgingChronic DiseaseClinicalClinical PharmacologyClinical ResearchClinical TrialsClinical Trials DesignCognitiveCollaborationsCommunitiesDevelopmentDiamondDiseaseEducationElderlyEpigenetic ProcessExerciseFoundationsFundingGDF8 geneGerontologyGeroscienceGoalsGrantHumanImmuneInflammationInformaticsInfrastructureInstitutionInterventionK-Series Research Career ProgramsKnowledgeLaboratoriesLeadershipLongevityMaintenanceMediatorMetabolic dysfunctionMetforminMethylene blueMitochondriaModelingMonkeysOxytocinPatientsPharmacologyPhasePilot ProjectsPlayPolicy MakerPrincipal InvestigatorProcessQualifyingResearchResearch DesignResearch PersonnelResearch SupportResourcesScientistSeriesServicesShockSirolimusSiteTestingTrainingTranslatingbench to bedsideclinical centerdata managementdisabilitydrug developmentdysbiosiseducation researchexhaustionfirst-in-humanfrailtygut microbiomehealthspanhealthy aginghuman diseaseimprovedinnovationknowledge baselifestyle interventionmTOR Inhibitormeetingsmicrobiomemild cognitive impairmentmultidisciplinarynonhuman primatenutritionoperationoral microbiomepharmacologicpre-clinical researchprogramsrecruitsarcopeniasenescenceskillssquare footstem cellsstress reductionsymposiumtrial designweb site
项目摘要
A core tenet of the geroscience concept is that multiple human diseases arise from aging itself. Thus, the
central theme of the San Antonio (SA) Claude D. Pepper Older Americans Independence Center (OAIC)
is translational geroscience – moving research on the basic biology of aging from the laboratory bench to the
clinic, with the overarching goal of promoting healthy aging and developing desperately needed treatments,
mainly pharmacological, for aging-related diseases. This goal is achieved through the following Aims:
1) Expand the knowledge base in translational geroscience by catalyzing transformative research; 2) Create
a cadre of multidisciplinary early-stage investigators with customized expertise in translational geroscience; 3)
Serve as a resource and partner to investigators from other OAICs and institutions; and 4) Provide intellectual
leadership, disseminate knowledge, and stimulate discussion on translational geroscience-related themes.
The SA OAIC achieves these Aims through a Leadership and Administrative Core (LAC) that directs
operations and sponsors several enrichment and dissemination activities; a Pilot and Exploratory Studies Core
(PESC) that provides merit-based support for rigorously designed studies; a Research Education Component
(REC) that expands a greatly needed cadre of uniquely qualified scientists cross-trained in aging biology and
translational geroscience; a Pre-Clinical Research Core (RC1) which supports research in marmoset monkeys;
a Clinical Research and Pharmacology Core (RC2) that delivers comprehensive trial support for
recruitment/retention, assessments, pharmacology, and data management; and a Trial Design and Integrative
Informatics Core (RC3) that provides comprehensive study design, biostatistics and informatics services.
During the ~4 years since its funding, the SA OAIC supported 46 PIs, performing transformative translational
geroscience-focused research in essentially all pillars/hallmarks of aging. For example, RC1 is conducting the
only known lifespan and healthspan study on mTOR inhibitors in nonhuman primates. RC2 and RC3 carried out
the first trial on rapamycin to examine immune and cognitive effects in healthy older adults and performed the
first-in-man studies on senolytics. The OAIC supported 10 Scholars who are making transformative discoveries
(e.g. first demonstration of cellular senescence as a key mediator of Alzheimer's pathology) and receiving highly
competitive career development awards from the NIA/AFAR (Beeson, Irene Diamond) and the VA.
The SA OAIC is built on a unique foundation provided by UTHSCSA's exceptional and tightly integrated
resources: a Nathan Shock Center, a site of the Interventions Testing Program (ITP), a GRECC, a T32 Training
Grant on Geroscience, and a robust Barshop Institute that unites aging research at UTHSCSA. We are the only
OAIC with all of these synergistic components available. In addition, the SA OAIC receives unparalleled
institutional commitment (~$600,000/year), including a new ~$100M 109,000 sq. ft. building – specific for the
Barshop Institute – that will house the OAIC, Shock Center, and the ITP in a centrally located facility.
老年科学概念的核心原则是多种人类疾病都是由衰老本身引起的。因此,
圣安东尼奥 (SA) 克劳德·D·佩珀 (Claude D. Pepper) 美国老年人独立中心 (OAIC) 的中心主题
是转化性老年科学——将衰老的基础生物学研究从实验室推向现实
诊所的总体目标是促进健康老龄化和开发急需的治疗方法,
主要是药理作用,用于与衰老相关的疾病。这一目标是通过以下目标实现的:
1) 通过促进变革性研究,扩大转化老年科学的知识基础; 2)创建
一支由多学科早期研究人员组成的骨干队伍,具有转化老年科学方面的定制专业知识; 3)
充当其他 OAIC 和机构调查人员的资源和合作伙伴; 4)提供智力
领导力、传播知识并激发对转化老年科学相关主题的讨论。
SA OAIC 通过领导和行政核心 (LAC) 来实现这些目标,该核心负责指导
运营并赞助多项丰富和传播活动;试点和探索性研究核心
(PESC) 为严格设计的研究提供择优支持;研究教育的组成部分
(REC)扩大了急需的一支由独特合格的科学家组成的骨干队伍,他们在衰老生物学和
转化老年科学;支持狨猴研究的临床前研究核心(RC1);
临床研究和药理学核心 (RC2),为以下患者提供全面的试验支持
招募/保留、评估、药理学和数据管理;以及试验设计和综合
信息学核心 (RC3),提供全面的研究设计、生物统计学和信息学服务。
自资助以来的约 4 年时间里,SA OAIC 支持了 46 名 PI,进行了变革性的转化
以老年科学为重点的研究,涉及衰老的几乎所有支柱/标志。例如,RC1 正在执行
唯一已知的针对非人类灵长类动物的 mTOR 抑制剂寿命和健康寿命的研究。 RC2 和 RC3 已完成
第一项雷帕霉素试验,旨在检查健康老年人的免疫和认知影响,并进行了
关于 senolytics 的首次人体研究。 OAIC 支持 10 名做出变革性发现的学者
(例如首次证明细胞衰老是阿尔茨海默病病理学的关键介质)并受到高度评价
NIA/AFAR(Beeson、Irene Diamond)和 VA 颁发的竞争性职业发展奖。
SA OAIC 建立在 UTHSCSA 卓越且紧密集成的独特基础之上
资源:内森休克中心、干预测试计划 (ITP) 站点、GRECC、T32 培训
Geroscience 的资助,以及一个强大的 Barshop 研究所,该研究所将 UTHSCSA 的老龄化研究结合起来。我们是唯一
OAIC 具有所有这些可用的协同组件。此外,SA OAIC 还获得无与伦比的
机构承诺(约 600,000 美元/年),包括约 1 亿美元的 109,000 平方英尺的新建筑 - 专门用于
Barshop Institute – 将在中心设施中容纳 OAIC、休克中心和 ITP。
项目成果
期刊论文数量(105)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Binge eating among older women: prevalence rates and health correlates across three independent samples.
- DOI:10.1186/s40337-021-00484-8
- 发表时间:2021-10-19
- 期刊:
- 影响因子:4.1
- 作者:Wilfred SA;Becker CB;Kanzler KE;Musi N;Espinoza SE;Kilpela LS
- 通讯作者:Kilpela LS
Association of Insurance Type With Colorectal Surgery Outcomes and Costs at a Safety-Net Hospital: A Retrospective Observational Study.
- DOI:10.1097/as9.0000000000000215
- 发表时间:2022-12
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
The association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injury.
- DOI:10.1186/s13195-023-01301-x
- 发表时间:2023-09-12
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of Dietary Intake Through Whole Foods on Cognitive Function: Review of Randomized Controlled Trials.
通过全食摄入膳食对认知功能的影响:随机对照试验回顾。
- DOI:10.1007/s13668-022-00412-5
- 发表时间:2022
- 期刊:
- 影响因子:4.9
- 作者:Jiwani,Rozmin;Robbins,Ronna;Neri,Alfonso;Renero,Jose;Lopez,Emme;Serra,MonicaC
- 通讯作者:Serra,MonicaC
Association of Insurance Type With Inpatient Surgery 30-Day Complications and Costs.
保险类型与住院手术 30 天并发症和费用的关联。
- DOI:10.1016/j.jss.2022.09.006
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Simon,RichardC;Kim,Jeongsoo;Schmidt,Susanne;Brimhall,BradleyB;Salazar,CamerinoI;Wang,Chen-Pin;Wang,Zhu;Sarwar,ZaheerU;Manuel,LauraS;Damien,Paul;Shireman,PaulaK
- 通讯作者:Shireman,PaulaK
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RANDY STRONG其他文献
RANDY STRONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RANDY STRONG', 18)}}的其他基金
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10702045 - 财政年份:2023
- 资助金额:
$ 124.26万 - 项目类别:
Detoxification of Biogenic Aldehydes in Parkinson's Disease
生物醛在帕金森病中的解毒作用
- 批准号:
10516030 - 财政年份:2013
- 资助金额:
$ 124.26万 - 项目类别:
Detoxification of Biogeneic Aldehydes in Parkinson's Disease
生物醛在帕金森病中的解毒作用
- 批准号:
8440618 - 财政年份:2013
- 资助金额:
$ 124.26万 - 项目类别:
Detoxification of Biogeneic Aldehydes in Parkinson's Disease
生物醛在帕金森病中的解毒作用
- 批准号:
8971961 - 财政年份:2013
- 资助金额:
$ 124.26万 - 项目类别:
Detoxification of Biogenic Aldehydes in Parkinson's Disease
生物醛在帕金森病中的解毒作用
- 批准号:
10043827 - 财政年份:2013
- 资助金额:
$ 124.26万 - 项目类别:
Detoxification of Biogeneic Aldehydes in Parkinson's Disease
生物醛在帕金森病中的解毒作用
- 批准号:
8666526 - 财政年份:2013
- 资助金额:
$ 124.26万 - 项目类别:
Detoxification of Biogenic Aldehydes in Parkinson's Disease
生物醛在帕金森病中的解毒作用
- 批准号:
10291812 - 财政年份:2013
- 资助金额:
$ 124.26万 - 项目类别:
Center for Testing Potential Anti-Aging Interventions
潜在抗衰老干预测试中心
- 批准号:
10165431 - 财政年份:2004
- 资助金额:
$ 124.26万 - 项目类别:
相似海外基金
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 124.26万 - 项目类别:
Research Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 124.26万 - 项目类别:
Continuing Grant
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 124.26万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 124.26万 - 项目类别:
Continuing Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 124.26万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 124.26万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 124.26万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 124.26万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 124.26万 - 项目类别:
Continuing Grant
Study of the Particle Acceleration and Transport in PWN through X-ray Spectro-polarimetry and GeV Gamma-ray Observtions
通过 X 射线光谱偏振法和 GeV 伽马射线观测研究 PWN 中的粒子加速和输运
- 批准号:
23H01186 - 财政年份:2023
- 资助金额:
$ 124.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




